Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of the Bio-Plex Pro Human Cytokine Screening Panel, the first validated high-performance multiplex assay on the market. The ...

Bio-Rad Laboratories announced today the availability of a guide (bulletin number 5650), entitled “Bio-Plex Pro™ Human Acute Phase Assay Panel,” which describes the reliable multiplex measurement of ...

The Bio-Plex Pro™ Mouse Chemokine Panel offers the ability to map out entire networks of biomarkers — up to 33 biologically relevant mouse chemokines and cytokines — in a single run from small amounts ...

For research purposes, Myriad RBM grants Bio-Rad exclusive distribution rights to a catalog of quantitative multiplexed immunoassays currently available to run on the Bio-Plex® 200, Bio-Plex® 3D ...